Wendy K. Chung's most recent trade in Prime Medicine Inc was a trade of 45,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Aug. 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Prime Medicine Inc | Wendy K. Chung | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Aug 2025 | 45,000 | 0 | - | - | Stock Option (right to buy) | |
| Prime Medicine Inc | Wendy K. Chung | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2025 | 45,000 | 45,000 | - | - | Stock Option (right to buy) | |
| Prime Medicine Inc | Wendy K. Chung | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2025 | 39,062 | 39,062 | - | - | Stock Option (right to buy) | |
| Prime Medicine Inc | Wendy K. Chung | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Aug 2025 | 39,062 | 0 | - | - | Stock Option (right to buy) | |
| Prime Medicine Inc | Wendy K. Chung | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Aug 2025 | 13,510 | 0 | - | - | Stock Option (right to buy) | |
| Prime Medicine Inc | Wendy K. Chung | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2025 | 13,510 | 13,510 | - | - | Stock Option (right to buy) | |
| Prime Medicine Inc | Wendy K. Chung | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2025 | 9,006 | 9,006 | - | - | Stock Option (right to buy) | |
| Prime Medicine Inc | Wendy K. Chung | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Aug 2025 | 9,006 | 0 | - | - | Stock Option (right to buy) | |
| Prime Medicine Inc | Wendy K. Chung | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 55,000 | 55,000 | - | - | Stock Option (right to buy) | |
| Rallybio Corp | Wendy K. Chung | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2025 | 28,500 | 28,500 | - | - | Option (Right to Buy) | |
| Prime Medicine Inc | Wendy K. Chung | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 45,000 | 45,000 | - | - | Stock Option (right to buy) | |
| Rallybio Corp | Wendy K. Chung | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 16,500 | 16,500 | - | - | Option (Right to Buy) | |
| Prime Medicine Inc | Wendy K. Chung | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 39,062 | 39,062 | - | - | Stock Option (right to buy) | |
| Rallybio Corp | Wendy K. Chung | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 9,482 | 9,482 | - | - | Option (Right to Buy) | |
| Prime Medicine Inc | Wendy K. Chung | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Oct 2022 | 9,006 | 9,006 | - | - | Stock Option (right to buy) | |
| Rallybio Corp | Wendy K. Chung | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2022 | 26,880 | 26,880 | - | - | Option (Right to Buy) |